1995
DOI: 10.3109/10715769509065257
|View full text |Cite
|
Sign up to set email alerts
|

The Free Radical Scavenger, α-Lipoic Acid, Protects Against Cerebral Ischemia-Reperfusion Injury in Gerbils

Abstract: alpha-Lipoic acid (thioctic acid) was tested for its neuroprotective activity in a Mongolian gerbil model of forebrain ischemia/reperfusion. Adult gerbils were treated for 7 days with two intraperitoneal injections per day of alpha-lipoic acid (20 mg/kg), vehicle or saline and on the 7th day the animals were subjected to 5 min of forebrain ischemia. Ischemic injury was assessed by monitoring the increases in locomotor activity and from the extent of damage to the CA1 hippocampal pyramidal cell layer after 5 da… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
35
0
1

Year Published

2003
2003
2018
2018

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(36 citation statements)
references
References 24 publications
0
35
0
1
Order By: Relevance
“…Although OTC or ␣-lipoic acid has been studied clinically for the treatment of oxidant-induced diseases, such as ischemia-reperfusion injury (Cao and Phillis, 1995), diabetic neuropathy (van Dam, 2002), and coronary artery disease (Vita et al, 1998), there are no clinical studies using OTC or ␣-lipoic acid for airway diseases. The calculated human equivalent dose of the murine oral dosage of ␣-lipoic acid in this study is within the reported range of the therapeutic dose of ␣-lipoic acid in human diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Although OTC or ␣-lipoic acid has been studied clinically for the treatment of oxidant-induced diseases, such as ischemia-reperfusion injury (Cao and Phillis, 1995), diabetic neuropathy (van Dam, 2002), and coronary artery disease (Vita et al, 1998), there are no clinical studies using OTC or ␣-lipoic acid for airway diseases. The calculated human equivalent dose of the murine oral dosage of ␣-lipoic acid in this study is within the reported range of the therapeutic dose of ␣-lipoic acid in human diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have demonstrated α-lipoic acid cytoprotective action against reperfusion injury in animal models of global 23,24 and focal 25 cerebral ischemia. C -II C-II C-II C -II C -II C -II C -II C -II C -II C -II C -II Groups C -III C -III I-II C -III C -III I -II I -II I -II I -II I -II I -II I -II C -I III -II III -II III -II I - Our demonstrations that 3.03 mM α-lipoic acid infusion promotes initial reduction and final partial EEG spectra mean absolute amplitude recuperation, allowed us to speculate that, in this condition, this substance has an initial pro-oxidant and a late antioxidant action.…”
Section: Discussionmentioning
confidence: 99%
“…The cysteine derivatives N-acetylcysteine and carbocysteine have been used to block inflammation and hyper-reactivity in animal models of asthma (Asti et al, 1995;Blesa et al, 2002). ␣-Lipoic acid, which is a naturally occurring antioxidant, has recently been used clinically for the treatment of oxidant-induced diseases (Cao and Phillis, 1995;Ametov et al, 2003). Cho et al (2004) have shown that ␣-lipoic acid reduces airway inflammation Fig.…”
Section: Discussionmentioning
confidence: 99%